BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20964113)

  • 1. Marfan syndrome: clinical manifestations, pathophysiology and new outlook on drug therapy.
    Lebreiro A; Martins E; Cruz C; Almeida J; Maciel MJ; Cardoso JC; Lima CA
    Rev Port Cardiol; 2010 Jun; 29(6):1021-36. PubMed ID: 20964113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
    De Backer J
    Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome.
    Singh KK; Rommel K; Mishra A; Karck M; Haverich A; Schmidtke J; Arslan-Kirchner M
    Hum Mutat; 2006 Aug; 27(8):770-7. PubMed ID: 16799921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and Japanese clinical characteristics in Marfan syndrome.
    Fujita D; Takeda N; Imai Y; Inuzuka R; Komuro I; Hirata Y
    Pediatr Int; 2014 Aug; 56(4):484-91. PubMed ID: 24931486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent molecular biological progress in Marfan syndrome and Marfan-associated disorders.
    Gao LG; Luo F; Hui RT; Zhou XL
    Ageing Res Rev; 2010 Jul; 9(3):363-8. PubMed ID: 19772952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and Management of Cardiovascular Manifestations in Marfan and Loeys-Dietz Syndromes.
    Takeda N; Yagi H; Hara H; Fujiwara T; Fujita D; Nawata K; Inuzuka R; Taniguchi Y; Harada M; Toko H; Akazawa H; Komuro I
    Int Heart J; 2016 May; 57(3):271-7. PubMed ID: 27181042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular manifestations and treatment in Marfan syndrome].
    Erentuğ V; Polat A; Kirali K; Akinci E; Yakut C
    Anadolu Kardiyol Derg; 2005 Mar; 5(1):46-52. PubMed ID: 15755703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The research progress in Marfan syndrome].
    Zhu SH; Liu L
    Fa Yi Xue Za Zhi; 2005 Feb; 21(1):58-60. PubMed ID: 15895810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of Marfan syndrome.
    Iams HD
    Curr Sports Med Rep; 2010; 9(2):93-8. PubMed ID: 20220350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ehlers-Danlos syndromes and Marfan syndrome.
    Callewaert B; Malfait F; Loeys B; De Paepe A
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):165-89. PubMed ID: 18328988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of periodontitis on cardiovascular manifestations in Marfan syndrome. Critical common role of TGF-β.
    Suzuki J; Aoyama N; Izumi Y; Isobe M; Komuro I; Hirata Y
    Int Heart J; 2015; 56(2):121-4. PubMed ID: 25740392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marfan syndrome: from molecular pathogenesis to clinical treatment.
    Ramirez F; Dietz HC
    Curr Opin Genet Dev; 2007 Jun; 17(3):252-8. PubMed ID: 17467262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skeletal and occlusal alterations in the diagnosis of Marfan syndrome].
    Incisivo V; Silvestri A
    Minerva Stomatol; 2003 Oct; 52(10):457-69. PubMed ID: 14765031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous TGFBR2 mutations in Marfan syndrome.
    Mizuguchi T; Collod-Beroud G; Akiyama T; Abifadel M; Harada N; Morisaki T; Allard D; Varret M; Claustres M; Morisaki H; Ihara M; Kinoshita A; Yoshiura K; Junien C; Kajii T; Jondeau G; Ohta T; Kishino T; Furukawa Y; Nakamura Y; Niikawa N; Boileau C; Matsumoto N
    Nat Genet; 2004 Aug; 36(8):855-60. PubMed ID: 15235604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In search of a new therapeutic target for the treatment of genetically triggered thoracic aortic aneurysms and cardiovascular conditions: insights from human and animal lathyrism.
    Sherif HM
    Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):271-6. PubMed ID: 20547706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome.
    Hartog AW; Franken R; Zwinderman AH; Groenink M; Mulder BJ
    Expert Opin Pharmacother; 2012 Apr; 13(5):647-62. PubMed ID: 22397493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marfan syndrome: what internists and pediatric or adult cardiologists need to know.
    Kaemmerer H; Oechslin E; Seidel H; Neuhann T; Neuhann IM; Mayer HM; Hess J
    Expert Rev Cardiovasc Ther; 2005 Sep; 3(5):891-909. PubMed ID: 16181034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts of ocular manifestations in Marfan syndrome.
    Nemet AY; Assia EI; Apple DJ; Barequet IS
    Surv Ophthalmol; 2006; 51(6):561-75. PubMed ID: 17134646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marfan syndrome-diagnosis and management.
    Ammash NM; Sundt TM; Connolly HM
    Curr Probl Cardiol; 2008 Jan; 33(1):7-39. PubMed ID: 18155514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Marfan syndrome.
    Pyeritz RE
    Annu Rev Med; 2000; 51():481-510. PubMed ID: 10774478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.